ClinicalTrials.gg
Active, not recruitingNCT06838455Updated Nov 6, 2026

Effectiveness of Therapeutic Exercises on Spinopelvic Mobility

An interventional study of Spinopelvic mobility exercise in Osteoarthritis (OA) of the Hip, sponsored by Colorado Joint Replacement. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Colorado Joint Replacement · Not applicable, Interventional, and Diagnostic

How we know

Updated Nov 6, 2026Now Active, not recruitingFirst site in United States+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 1,029 studies in Osteoarthritis with a site in United States — 116 open to participants now, 175 under way, 14 of them phase 3. Osteoarthritis · United States.

Planned enrollment
570th of 832
53 · median 100
Started
2025
with 36 others
No phase
437 of 1,029
54 open now
Primary completion
2026-07
later than 45 of 174 live
Registered
973rd of 1,029
by date

Among the 1,029 studies in Osteoarthritis with a site in United States, this one is the 570th largest by planned enrollment of the 832 interventional ones that give a count, is one of 37 that started in 2025, is one of 437 with no phase, reaches primary completion later than 45 of the 174 other live ones, and was the 973rd registered.

Osteoarthritis

2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

Browse Osteoarthritis studies →

Open to participants now

116 of the 1,029 studies in Osteoarthritis with a site in United States are open now. Recruiting first, the newest first:

111 more — sign in →

All 116 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,029 studies in Osteoarthritis with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to examine the extent to which spinopelvic exercises may affect either sagittal spinal deformity or spinopelvic mobility and identifying patients at risk for hip instability following a total hip replacement.

03

Conditions studied

  • Osteoarthritis (OA) of the Hip

Browse trials for

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients aged 18-90 scheduled for total hip arthroplasty
  2. Patients with primary hip osteoarthritis
  3. Patients with or without history of prior spinal injections

Exclusion criteria

Exclusion Criteria:

  1. Patients undergoing revision total hip arthroplasty.
  2. Patients with spinal fusion.
  3. Patients who exercised prior to radiographic analysis.
  4. Patients unable to complete imaging at the designated time of day.
  5. Symptomatic contralateral hip osteoarthritis.
  6. Patients unwilling or unable to perform therapeutic exercise program as instructed. This includes patients requiring use of assistive devices or who would be deemed unsafe to perform the exercises without a 1- or 2-person assist.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
53 participants (estimated)

Study arms

  • Experimental
    Spinopelvic Exercise

    Participants will complete a 15-20 min session of therapeutic exercises performed by patients with assistance of a pre-recorded video.

    Other: Spinopelvic mobility exercise

Interventions

  • OtherSpinopelvic mobility exercise

    Participants will complete a 15-20 min session of therapeutic exercises performed by patients with assistance of a pre-recorded video. The exercise regimen has been developed by the investigators of this study to incorporate exercises to increase a patient's spinopelvic mobility. Study staff that has been properly trained will be present to guide the patient through the exercise regimen and ensure the exercises are being performed accurately.

06

What researchers measure

Primary outcomes

  1. Spinopelvic radiographic measurements

    Spinopelvic parameter measurements on pre- and post-exercise radiographs including pelvic incidence, pelvic tilt, sacral slope and lumbar lordosis. All measurements are angles calculated in degrees.

    Time frame: Change from baseline to up to 1 hour after spinopelvic exercises same day.

  2. Lumbar mobility

    Calculated as the change in angle of lumbar lordosis between neutral standing and flexed-forward seated radiographs.

    Time frame: Change from baseline to up to 1 hour after spinopelvic exercises same day

  3. Spinopelvic mobility

    Calculated as the change in angle of pelvic tilt between neutral standing and flexed-forward seated radiographs.

    Time frame: Change from baseline to up to 1 hour after spinopelvic exercises same day

  4. Patient risk classification for THA instability

    Risk classification based on previously published risk factors for THA instability (lumbar stiffness, abnormal pelvic mobility, standing pelvic tilt greater than 13, sagittal spinal deformity)

    Time frame: Change from baseline to up to 1 hour after spinopelvic exercises same day

Secondary outcomes

  1. Oswestry Disability Index score

    Patient reported outcome for pre-existing back pain and disability. The questionnaire is comprised of 10 sections, where each section is scored on a scale from 0 to 5 and summed. Higher score totals indicates worse disability.

    Time frame: Baseline

  2. Hip Society Score

    Patient reported outcome, scored from 0 to 100. Higher scores indicate better outcomes.

    Time frame: Baseline

  3. Hip disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS, JR)

    Patient reported outcome, scored from 0 to 100. Higher scores indicate better outcomes.

    Time frame: Baseline

  4. The Veterans Rand 12-Item Health Survey scores (VR-12)

    Patient reported outcome. Scores are reported as a Z-score that is based on the United States population average of 50. Higher scores indicate better outcomes.

    Time frame: Baseline

  5. Use of medication for hip/back pain

    Assessed by standard of care questionnaire prior to the pre-operative visit with provider for a total hip replacement.

    Time frame: Baseline

  6. Severity of hip arthritis

    Graded using Kellgren-Lawrence scale for osteoarthritis on AP radiographs. Grades are between 0-4, where 0 indicates an absence of osteoarthritis and a 4 indicates severe osteoarthritis.

    Time frame: Baseline

  7. Adverse events

    Any adverse events sustained from therapeutic exercises

    Time frame: Day 1

07

Study locations

1 site
  • AdventHealth Medical Group Colorado Joint Replacement
    Denver, Colorado 80210, United States
08

References and documents

Publications

  • Dagneaux L, Marouby S, Maillot C, Canovas F, Riviere C. Dual mobility device reduces the risk of prosthetic hip instability for patients with degenerated spine: A case-control study. Orthop Traumatol Surg Res. 2019 May;105(3):461-466. doi: 10.1016/j.otsr.2018.12.003. Epub 2018 Dec 26. PubMed 30594599 ↗
  • Haws BE, Khechen B, Patel DV, Louie PK, Iyer S, Cardinal KL, Guntin JA, Singh K. Sagittal Imbalance Does Not Influence Cup Anteversion in Total Hip Arthroplasty Dislocations. Clin Spine Surg. 2019 Feb;32(1):E31-E36. doi: 10.1097/BSD.0000000000000712. PubMed 30247184 ↗
  • Buckland AJ, Abotsi EJ, Vasquez-Montes D, Ayres EW, Varlotta CG, Vigdorchik JM. Lumbar Spine Degeneration and Flatback Deformity Alter Sitting-Standing Spinopelvic Mechanics-Implications for Total Hip Arthroplasty. J Arthroplasty. 2020 Apr;35(4):1036-1041. doi: 10.1016/j.arth.2019.11.020. Epub 2019 Nov 22. PubMed 31839349 ↗
  • Buckland AJ, Fernandez L, Shimmin AJ, Bare JV, McMahon SJ, Vigdorchik JM. Effects of Sagittal Spinal Alignment on Postural Pelvic Mobility in Total Hip Arthroplasty Candidates. J Arthroplasty. 2019 Nov;34(11):2663-2668. doi: 10.1016/j.arth.2019.06.036. Epub 2019 Jun 22. PubMed 31301908 ↗
  • Lum ZC, Coury JG, Cohen JL, Dorr LD. The Current Knowledge on Spinopelvic Mobility. J Arthroplasty. 2018 Jan;33(1):291-296. doi: 10.1016/j.arth.2017.08.013. Epub 2017 Aug 24. PubMed 28939031 ↗
  • Murphy WS, Yun HH, Hayden B, Kowal JH, Murphy SB. The Safe Zone Range for Cup Anteversion Is Narrower Than for Inclination in THA. Clin Orthop Relat Res. 2018 Feb;476(2):325-335. doi: 10.1007/s11999.0000000000000051. PubMed 29529664 ↗
  • Abdel MP, von Roth P, Jennings MT, Hanssen AD, Pagnano MW. What Safe Zone? The Vast Majority of Dislocated THAs Are Within the Lewinnek Safe Zone for Acetabular Component Position. Clin Orthop Relat Res. 2016 Feb;474(2):386-91. doi: 10.1007/s11999-015-4432-5. PubMed 26150264 ↗
  • Esposito CI, Carroll KM, Sculco PK, Padgett DE, Jerabek SA, Mayman DJ. Total Hip Arthroplasty Patients With Fixed Spinopelvic Alignment Are at Higher Risk of Hip Dislocation. J Arthroplasty. 2018 May;33(5):1449-1454. doi: 10.1016/j.arth.2017.12.005. Epub 2017 Dec 13. PubMed 29310920 ↗
  • Tezuka T, Heckmann ND, Bodner RJ, Dorr LD. Functional Safe Zone Is Superior to the Lewinnek Safe Zone for Total Hip Arthroplasty: Why the Lewinnek Safe Zone Is Not Always Predictive of Stability. J Arthroplasty. 2019 Jan;34(1):3-8. doi: 10.1016/j.arth.2018.10.034. Epub 2018 Nov 2. PubMed 30454867 ↗
  • Ike H, Dorr LD, Trasolini N, Stefl M, McKnight B, Heckmann N. Spine-Pelvis-Hip Relationship in the Functioning of a Total Hip Replacement. J Bone Joint Surg Am. 2018 Sep 19;100(18):1606-1615. doi: 10.2106/JBJS.17.00403. No abstract available. PubMed 30234627 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in Jul 2026, 13 months.

Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's 13 months is below that.

Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: start Feb 2025 → May 2025, primary completion Jun 2025 → Jul 2026 and completion Dec 2025 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2025
First posted
Feb 20, 2025
StartActual
May 16, 2025was Feb 2025
Primary completionActual
Jul 1, 2026was Jun 2025
CompletionEst.
Dec 2026was Dec 2025
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Active, not recruiting
changed Nov 6, 2026
Sites
1 site added — first site in United States
Show site
  • AdventHealth Medical Group Colorado Joint Replacement · Denver, United States
Nov 6, 2026
Start date
Feb 2025→May 16, 2025 (actual)
Nov 6, 2026
Primary completion
Jun 2025→Jul 1, 2026 (actual)
Nov 6, 2026
Study completion
Dec 2025→Dec 2026
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Not yet recruiting→Active, not recruiting
    1 site added — first site in United States
    Show site
    • AdventHealth Medical Group Colorado Joint Replacement · Denver, United States
    Start date Feb 2025→May 16, 2025 (now actual)
    Primary completion Jun 2025→Jul 1, 2026 (now actual)
    Study completion Dec 2025→Dec 2026
    + 4 other changes: index terms, verification date, oversight details and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06838455
Lead sponsor
Colorado Joint Replacement
Responsible party
Jason Jennings (Orthopedic Surgeon, Colorado Joint Replacement) — Principal investigator
First posted
Feb 20, 2025
Start date
May 16, 2025
Primary completion
Jul 1, 2026
Completion
Dec 2026 (estimated)
Last update
Nov 6, 2026

Study contacts

Dennis Douglas, MD
principal investigator · Colorado Joint Replacement

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion